Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

See all formats and pricing
In This Section
Volume 45, Issue 12 (Dec 2007)


The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial

Markus Herrmann
  • 1ANZAC Research Institute, University of Sydney, Sydney NSW, Australia and Department of Clinical Chemistry and Laboratory Medicine, University Hospital of Saarland, Homburg/Saar, Germany
/ Natalia Umanskaya
  • 2Department of Clinical Chemistry and Laboratory Medicine, University Hospital of Saarland, Homburg/Saar, Germany
/ Lydia Traber
  • 3Labor Limbach, Heidelberg, Germany
/ Heinrich Schmidt-Gayk
  • 4Labor Limbach, Heidelberg, Germany and Unfortunately, Prof. Heinrich Schmidt-Gayk deceased while this work was in progress.
/ Wolfgang Menke
  • 5Rehaklinik Saarschleife, Mettlach-Orscholz, Germany
/ Gerd Lanzer
  • 6Orthopedic Studio, Völklingen, Germany
/ Markus Lenhart
  • 7Orthopedic Studio, St. Wendel, Germany
/ Johannes Peter Schmidt
  • 8Department of Clinical Chemistry and Laboratory Medicine, University Hospital of Saarland, Homburg/Saar, Germany
/ Wolfgang Herrmann
  • 9Department of Clinical Chemistry and Laboratory Medicine, University Hospital of Saarland, Homburg/Saar, Germany
Published Online: 2007-12-08 | DOI: https://doi.org/10.1515/CCLM.2007.352


Background: Hyperhomocysteinemia is a new risk factor for osteoporosis. This study analyzed the effect of a homocysteine (HCY)-lowering treatment in osteoporotic individuals.

Methods: Osteoporotic subjects (n=47, 55–82 years) were treated with either a combination of 2.5 mg folate, 0.5 mg vitamin B12 and 25 mg vitamin B6 or placebo. Bone mineral density (BMD) at lumbar spine and hip was measured at baseline and after 1 year. Urinary desoxypyridinoline cross-links (DPD) and plasma levels of tartrate resistant acid phosphatase (TRAP), C-terminal cross-links of collagen I (CTx), pro-collagen type I N-terminal peptide (PINP) and osteocalcin (OC) were measured after 0, 4, 8 and 12 months.

Results: B-vitamin supplementation significantly reduced HCY (0 vs. 12 months: 13.6±4.8 vs. 8.9±2.4 μmol/L). Placebo treatment had no effect on HCY (0 vs. 12 months: 12.0±3.4 vs. 12.7±3.9μmol/L). BMD, TRAP, CTx, OC and PINP did not change throughout the study in both groups. Vitamin treatment decreased urinary DPD by –13% (p<0.01) after 8 and 12 months. In a sub-group analysis of hyperhomocysteinemic subjects (HCY>15 μmol/L, n=8), B-vitamin treatment tended to increase BMD at the lumbar spine, with a t-score from –2.7 to –1.7, and to decrease OC and PINP by approximately 50%.

Conclusions: B-vitamin supplementation had no consistent effects on bone turnover or BMD. However, the situation may be different in patients with hyperhomocysteinemia.

Clin Chem Lab Med 2007;45:1785–92.

Keywords: bone mineral density; C-terminal telopeptides of collagen I (CTx); folate; homocysteine; osteocalcin; pro-collagen type I N-terminal peptide (PINP); tartrate-resistant acid phosphatase (TRAP); urinary desoxypyridinoline cross-links (DPD); vitamin B6; vitamin B12

About the article

Corresponding author: Dr. Markus Herrmann, ANZAC Research Institute, Bone Research Program, Gate 3, Hospital Road, Concord, NSW 2139, Australia Phone: +61-2-9767-9165, Fax: +61-2-9767-9101,

Received: 2007-08-15

Accepted: 2007-10-01

Published Online: 2007-12-08

Published in Print: 2007-12-01

Citation Information: Clinical Chemical Laboratory Medicine, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: https://doi.org/10.1515/CCLM.2007.352. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Fiona O’Leary and Samir Samman
Nutrients, 2010, Volume 2, Number 3, Page 299
J. P. van Wijngaarden, E. L. Doets, A. Szczecińska, O. W. Souverein, M. E. Duffy, C. Dullemeijer, A. E. J. M. Cavelaars, B. Pietruszka, P. van't Veer, A. Brzozowska, R. A. M. Dhonukshe-Rutten, and C. P. G. M. de Groot
Journal of Nutrition and Metabolism, 2013, Volume 2013, Page 1
Irena Keser, Jasminka Z. Ilich, Nada Vrkić, Zlatko Giljević, and Irena Colić Barić
Nutrition Research, 2013, Volume 33, Number 3, Page 211
Nisha Nigil Haroon, Raman K. Marwaha, Madan M. Godbole, and Sushil K. Gupta
Journal of Clinical Densitometry, 2012, Volume 15, Number 3, Page 366
C. de jaeger, N. Fraoucene, E. Voronska, and P. Cherin
Médecine & Longévité, 2010, Volume 2, Number 2, Page 73
Cathi Dennehy and Candy Tsourounis
Maturitas, 2010, Volume 66, Number 4, Page 370
Rifka C. Schulman, Aaron J. Weiss, and Jeffrey I. Mechanick
Current Osteoporosis Reports, 2011, Volume 9, Number 4, Page 184
Amany K. Elshorbagy, Clara Gram Gjesdal, Eha Nurk, Grethe S. Tell, Per M. Ueland, Ottar Nygård, Aage Tverdal, Stein E. Vollset, A. David Smith, and Helga Refsum
Bone, 2009, Volume 44, Number 5, Page 954
Markus Herrmann, Johannes Peter Schmidt, Natalia Umanskaya, Alexandra Wagner, Omid Taban-Shomal, Thomas Widmann, Graziana Colaianni, Britt Wildemann, and Wolfgang Herrmann
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 12
Kelly T. Williams and Kevin L. Schalinske
BioFactors, 2010, Page NA
Katherine L. Tucker
Current Osteoporosis Reports, 2009, Volume 7, Number 4, Page 111

Comments (0)

Please log in or register to comment.
Log in